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Introduction
In mammalian cells, two major checkpoints ensure the fidelity 
of DNA replication. The intra–S phase checkpoint is elicited by 
exogenously inflicted DNA damage that creates double-strand 
breaks (DSBs) and is controlled by the PI3-like kinase ataxia 
telangiectasia mutated (ATM). ATM can be activated in every 
phase of the cell cycle, including S phase, and the main signal 
transducer is Chk2 (for review see Cimprich and Cortez, 2008). 
Neither Chk2 nor ATM are essential genes (Barlow et al., 1996; 
Elson et al., 1996; Xu et al., 1996; Hirao et al., 2002; Takai   
et al., 2002). The second and essential checkpoint (hitherto re-
ferred as the DNA replication checkpoint) monitors the process 
of DNA replication itself and is activated by single-stranded 
DNA (ssDNA) accumulated at stalled replication forks. The ac-
tivation of the checkpoint depends on another PI3-like kinase, 
ataxia telangiectasia and Rad3 related (ATR), and its main signal 
transducer is Chk1 (for review see Cimprich and Cortez, 2008). 
Errors in DNA replication are the main source of endogenous 
DNA  damage,  and  genes  required  for  the  DNA  replication 
checkpoint are essential (Liu et al., 1994; Brown and Baltimore, 
2000; Takai et al., 2000; Weiss et al., 2000; Yamane et al., 2002; 
Budzowska et al., 2004; Hopkins et al., 2004). Activation of the 
DNA replication checkpoint arrests the cell cycle and activates 
the  homologous  recombination  pathway,  which  mediates   
the restart of the arrested replication fork (for review see 
Lambert et al., 2007).
We have previously shown that Rif1 participates in the   
intra–S phase checkpoint, contributing to the inhibition of DNA 
replication associated with the activation of ATM (Silverman   
et al., 2004). Human Rif1 localizes to DSBs induced by a vari-
ety of clastogenic agents but not to DNA lesions generated by 
UV radiation. This association with DSBs is dependent on the 
activation of the ATM kinase and the DNA damage response 
factor 53BP1 (Schultz et al., 2000; Silverman et al., 2004).
Rif1 was originally identified in budding yeast based on its 
ability to interact with Rap1, a protein which plays a key role 
at telomeres (Hardy et al., 1992). By tethering Rif1 and a sec-
ond Rap1-interacting factor, Rif2, Rap1 can limit the action of 
telomerase in cis and thus establish telomere length homeostasis 
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if1, originally recognized for its role at telomeres in 
budding yeast, has been implicated in a wide vari­
ety of cellular processes in mammals, including pluri­
potency of stem cells, response to double­strand breaks, 
and breast cancer development. As the molecular function 
of Rif1 is not known, we examined the consequences of 
Rif1 deficiency in mouse cells. Rif1 deficiency leads to fail­
ure in embryonic development, and conditional deletion 
of Rif1 from mouse embryo fibroblasts affects S­phase 
progression, rendering cells hypersensitive to replication 
poisons. Rif1 deficiency does not alter the activation of the 
DNA replication checkpoint but rather affects the execution 
of repair. RNA interference to human Rif1 decreases the 
efficiency of homology­directed repair (HDR), and Rif1 
deficiency results in aberrant aggregates of the HDR fac­
tor Rad51. Consistent with a role in S­phase progression, 
Rif1 accumulates at stalled replication forks, preferentially 
around pericentromeric heterochromatin. Collectively, these 
findings reveal a function for Rif1 in the repair of stalled forks 
by facilitating HDR.
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detected for wild-type Rif1 (unpublished data). Intercrosses of   
Rif1
GT/+ mice yielded homozygous Rif1
GT/GT offspring at a se-
verely reduced frequency (Fig. S1 F), suggesting a critical role 
for Rif1 during mouse development. In addition, examination 
of the genotypes of embryonic day (E) 12.5 embryos showed 
only one third of the expected number of Rif1
GT/GT embryos 
(Fig. S1 F), indicating that Rif1 contributes to embryonic de-
velopment at early as well as late stages. In addition, a con-
ventional knockout allele of Rif1, in which exons 8 and 9 were 
replaced with a Neomycin resistance (NeoR) cassette, resulted 
in embryonic lethality on a pure C57BL/6J background (un-
published data). These results are in contrast with the findings 
with ATM and 53BP1 knockout mice (Barlow et al., 1996; 
Elson et al., 1996; Xu et al., 1996; Morales et al., 2003; Ward 
et al., 2003), which are born at the expected Mendelian ratios 
and are fully viable. Therefore, the embryonic lethality indi-
cates that Rif1 has functions in addition to those downstream 
of ATM and 53BP1. Furthermore, the recovery of the Rif1-
deficient embryos at E12.5 (Fig. S1 F) argues that Rif1 is not 
essential for the function of Nanog, whose absence results in 
lethality around E5.5 (Mitsui et al., 2003).
The few Rif1
GT/GT mice born survived for at least 1 yr but 
appeared slightly retarded in their growth and were less fertile 
than their littermates (unpublished data). Because these rare 
Rif1
GT/GT survivors are likely reflecting some type of compen-
sation for the essential function of Rif1, we did not study 
them further.
Conditional deletion of Rif1 induces  
an S-phase defect
Given the diminished viability of Rif1-deficient embryos and 
the associated possibility of selection for compensation, we 
generated a conditional allele of Rif1. In the conditional allele 
(Rif1
F), LoxP target sites for the Cre recombinase were posi-
tioned 5 of exon 5 and 3 of exon 7 (Fig. 1 A). Mice homo-
zygous for the Rif1
F/F allele were born at the expected frequency, 
viable, healthy, and fertile (unpublished data). Fibroblasts were 
prepared from E12.5 Rif1
F/F, and wild-type littermate embryos 
were derived from Rif1
F/+ intercrosses. Cells were either used 
as primary cultures (pMEFs) or immortalized with SV40 large 
T antigen (SV40LT; MEFs). Infection with a Cre-expressing 
retrovirus efficiently generated the Rif1-null allele (Fig. 1, B and C). 
In  the  absence  of  Rif1,  primary  and  SV40LT  immortalized 
cells proliferated significantly slower than the controls (Fig. 1 D 
and not depicted), which is consistent with the findings from 
the Rif1
GT/GT cells (Fig. S1 G). Rif1-deficient cells, like Rif1
GT/GT 
pMEFs, also showed reduced uptake of BrdU during a 30-min 
pulse, indicating that the proliferation phenotype is (at least in 
part) caused by a defect in entry and/or progression through   
S phase (Fig. 1 E, Fig. S2 A, and not depicted). We could not 
detect any significant effect of Rif1 deletion on the amount of 
cells in G2/M based on FACS analysis of phosphorylated Ser10 
histone H3 (Fig. 1 F). Consistent with previous data on human 
Rif1 (Silverman et al., 2004), Rif1
/ cells revealed no obvious 
telomere defects such as telomere fusions or loss of telomeric 
DNA (Fig. S1 H and not depicted), arguing that their dimin-
ished proliferation is not telomere related. Thus, unlike the 
(Marcand et al., 1997; Levy and Blackburn, 2004; Bianchi and 
Shore, 2008). Rif2 is a diverged version of ORC4 that can bind 
to Rif1 as well as Rap1 (Wotton and Shore, 1997; Marcand   
et al., 2008). No other Rif1 interacting partners have been iden-
tified in yeast, and the mechanism by which Rif1 enforces the 
inhibition of telomerase has not been established. Orthologues 
of Rif1 and Rap1 (but not Rif2) have been recognized in 
Schizosaccharomyces pombe and in vertebrates (Li et al., 2000; 
Kanoh and Ishikawa, 2001; Li and de Lange, 2003; Adams 
and McLaren, 2004; Silverman et al., 2004). Although fission 
yeast Rif1 does not bind Rap1, it does interact with telomeres 
and contribute to telomere length homeostasis (Kanoh and 
Ishikawa, 2001).
So far there has been no indication of a conserved role for 
yeast and mammalian Rif1 orthologues. Mammalian Rif1 does 
not appear to bind normal telomeres nor to have a role in telo-
mere homeostasis (Silverman et al., 2004; Xu and Blackburn, 
2004; this study). Although rif1 budding yeast looses chromo-
somes at a slightly increased rate (Wotton and Shore, 1997;   
Banerjee and Myung, 2004), Rif1 deficiency does not affect the 
rate of gross chromosomal rearrangements (Myung et al., 2001), 
which are largely caused by the repair of S-phase damage. Sim-
ilarly, there is no data indicating that fission yeast Rif1 plays a 
prominent role in the response to S-phase damage.
In addition to regulation of telomere maintenance in bud-
ding yeast and response to DSBs in human cells, Rif1 has also 
been implicated in transcriptional silencing at yeast telomeres 
and ribosomal DNA (Hardy et al., 1992; Smith et al., 1999; Teng 
et al., 2000; Chan et al., 2001; Silverman et al., 2004; Teixeira   
et al., 2004) and in controlling mouse embryonic stem (ES) cells’ 
identity (Loh et al., 2006; Wang et al., 2006; Fazzio et al., 2008; 
Liang et al., 2008). Rif1 has no informative protein motifs or in-
teracting partners that could point to the molecular mechanism 
by which Rif1 contributes to these different pathways.
To gain further insight into the function of this enigmatic 
protein, we targeted Rif1 in the mouse, generating a setting in 
which the consequences of the absence of Rif1 could be stud-
ied. Our data reveal a new role for mammalian Rif1 in the con-
text  of  the  repair  machinery  that  is  mobilized  by  the  DNA 
replication checkpoint.
Results
Rif1 deficiency impairs embryonic 
development
To determine the consequences of Rif1 deficiency, we initially 
used a mouse ES cell line from a gene trap collection (Hansen 
et al., 2003) in which a pT1-GEO vector was integrated be-
tween exons 21 and 22 of the Rif1 gene (referred to as Rif1
GT; 
Fig. S1, A–D). This insertion generates a truncated allele, cod-
ing for a Rif1/-GEO fusion protein which lacks a nuclear 
localization signal (Fig. S1 E). Immunoblots of Rif1
GT/+ mouse 
embryonic fibroblasts (MEFs) showed diminished expression 
of  the  Rif1/-GEO  protein  compared  with  wild  type,  sug-
gesting that the truncated protein is unstable (Fig. S1 E). Fur-
thermore, as expected from the lack of a nuclear localization 
signal, Rif1/-GEO failed to show the specific nuclear signals 387 Rif1 modulates HDR at stalled forks • Buonomo et al.
et al., 1984). In wild-type cells, this treatment induces chro-
matid breaks and chromosomal fragments. The frequency of 
these anomalies was significantly elevated (threefold) in Rif1- 
deficient cells, suggesting an increase in fork-stalling frequency, 
a decrease in the stability of stalled forks, or a defective restart 
of the stalled replication fork. Other aberrations such as trans-
locations and radial chromosomes were not significantly altered 
in the Rif1-null setting (Fig. 2 B). In the absence of aphidi-
colin treatment, Rif1-null cells showed a spontaneous eleva-
tion of chromatid breaks and chromosomal fragments over the 
negligible background detected in Cre-treated wild-type cells. 
A similar breakage phenotype occurred in Rif1
GT/GT MEFs (un-
published data).
Because chromosome spreads showed that replication forks 
in Rif1-null cells are more sensitive to low doses of aphidicolin, 
we examined how Rif1 deficiency influenced the ability of cells to 
fungal Rif1 genes, mammalian Rif1 is required for normal 
cell proliferation.
Rif1 deficiency exacerbates sensitivity  
to aphidicolin
The reduced proliferation of Rif1-null cells and their dimin-
ished BrdU uptake suggested a role for Rif1 in S phase that 
is distinct from its ATM-dependent response to DSBs. There-
fore, we asked whether Rif1 deficiency affected the response 
to the DNA polymerase inhibitor aphidicolin. The effect of 
aphidicolin treatment was evaluated on metaphase chromo-
somes from Rif1-deficient immortalized MEFs or Cre-treated 
wild-type control cells (Fig. 2, A and B). The standard dose of 
aphidicolin used for this experiment does not inhibit cell cycle 
progression but slows replication fork progression and ren-
ders it more prone to stalling, especially at fragile sites (Glover 
Figure 1.  Conditional deletion of mouse Rif1 
affects  cell  growth.  (A)  Schematic  diagram 
of the mouse Rif1 locus, the targeting vector 
(pTV), the conditional Rif1 allele (FLOX), and 
the null allele (DEL). LoxP sites (triangles) flank 
exons 5, 6, and 7. FRT sites (circles) flank the 
NeoR gene. SacI (S) and BamHI (B) fragment 
sizes  are  indicated  for  each  genotype,  and 
the probes p1 and p2 are shown. f1, r1, and 
r2 are primers for genomic PCR. (B) Southern 
blots from MEF clones. Genomic DNA digested 
with  SacI  and  probed  with  p1.  The  MEFs 
were  infected  with  retrovirus  carrying  either 
an empty vector (Cre) or pWZL-Cre (+Cre). 
Length is indicated in kilobases. (C) Western 
blot  of  extracts  from  MEFs  of  the  indicated 
genotypes probed with mouse Rif1 antibody 
1240. mTOR was used as a loading control.   
(D) Growth curves of Rif1 wild type (WT) and 
two independent Rif1
F/F (F/F) MEF lines with 
and without treatment with Cre. (E) Changes in 
the S-phase index upon infection with Cre deter-
mined based on BrdU uptake during a 30-min   
pulse  of  asynchronous  populations  of  Rif1-
proficient and -deficient cells. The changes were 
quantified  by  calculating  the  percentage  of 
BrdU-positive cells in (Cre)  (+Cre)/(Cre).   
(F) The same quantification as in E was per-
formed for the G2/M cells by staining for his-
tone H3 phospho-Ser10 and FACS analysis. 
(D–F) Error bars represent SD.JCB • VOLUME 187 • NUMBER 3 • 2009   388
shown in Fig. S2 D), which is consistent with previous findings 
with RNAi to Rif1 in human cells (Silverman et al., 2004).
Rif1-null cells accumulate  
S phase–induced DNA damage
Aphidicolin treatment causes the activation of the DNA replica-
tion checkpoint, which ensures both the stability of the stalled 
forks and the activation of the DNA repair pathways responsible 
for fork restart (Casper et al., 2002; Cha and Kleckner, 2002; 
Sogo et al., 2002; Zachos et al., 2003; Calzada et al., 2005). 
The hypersensitivity to the aphidicolin treatment of the Rif1-
null cells could be explained either by a defect in some aspect 
of the ATR kinase cascade or by a problem during repair. To test 
the first possibility, we monitored the phosphorylation state of 
survive aphidicolin treatment (Fig. 2 C). Two independent Rif1
F/F 
MEF lines and a control wild-type line were treated with Cre re-
combinase and examined for their sensitivity to aphidicolin. Rif1 
deletion resulted in significantly diminished survival compared 
with Rif1-proficient cells. The sensitivity to agents interfering di-
rectly with DNA polymerases appeared to be specific. Rif1-null 
cells also showed an approximate sixfold increase in cell death after 
low doses of hydroxyurea (HU; Fig. S2 B). In contrast, treatment   
with the interstrand cross-linking agent mitomycin C (MMC; 
Fig. 2 D) or the topoisomerase inhibitor ICRF-193 (Fig. S2 C) did 
not affect cells in a Rif1-dependent manner. Ionizing radiation 
(IR)–induced DSBs only marginally affected the survival of Rif1-
null cells (1.3- and 2.5-fold reduced survival compared with Rif1-
proficient cells when irradiated with 1 Gy or 5 Gy, respectively, as 
Figure 2.  Rif1-null cells are hypersensitive to aphidicolin. (A) Representative examples of metaphase chromosomes from wild-type (left) or Rif1
F/F (right) 
cells treated with Cre and aphidicolin. Open arrows indicate chromatid breaks, the closed arrow indicates a fragment, and arrowheads indicate radial 
chromosomes. (B) Table summarizing chromosome anomalies scored by SKY analysis of metaphase spreads from MEFs of the indicated genotypes. Values 
in parentheses indicate percentages of chromosomes with the relevant abnormality. aph, aphidicolin. (C and D) Graphs of colony survival of MEFs with 
the indicated genotypes treated with aphidicolin (C) or MMC (D). Error bars represent SD. Bar, 10 µm.389 Rif1 modulates HDR at stalled forks • Buonomo et al.
elicited a low level of Chk1 phosphorylation, whereas the phos-
phorylation of Chk2 was not obviously elevated compared with 
wild-type cells (Fig. 3 B). The specific phosphorylation of Chk1 
and not Chk2 in Rif1-null cells is consistent with a defect in the 
repair of DNA damage in S phase. Rif1-null cells did not have a 
the ATR target Chk1. Aphidicolin treatment of Rif1-null cells 
induced the same level of Chk1 phosphorylation as in the Rif1-
proficient controls (Fig. 3 A), indicating that the main signal-
ing cascade of the DNA replication checkpoint does not require 
Rif1. In addition, Rif1 deletion itself, without additional treatment, 
Figure 3.  Rif1 deletion causes accumulation of DNA damage. (A and B) Western blotting for the phosphorylation state of Chk1 and -2. MEFs of the 
indicated genotypes were treated with aphidicolin (A) or analyzed untreated (B). Proteins were extracted and analyzed for total levels of Chk1, Chk1 
phosphorylation on Ser345, Chk2 phosphorylation, and levels of cyclin A. As a control, NIH3T3 cells were treated with aphidicolin (aph) or -irradiated 
(IR). (C and D) Cells were treated or not (no APH) with aphidicolin for 3 h and 30 min. The presence of the DNA damage is identified by IF for -H2AX and 
is quantified as the mean intensity of specific signal in the nuclei. The percentage of each cell population that showed a value of mean intensity signal >50 
was calculated for each time point. Data represent the mean ± SEM of two independent Rif1
F/F + Cre and the mean ± SD of three wild type (WT; Rif1 WT, 
Rif WT + Cre, and Rif1
F/F). (C) Mean intensity of -H2AX signal after 3 h and 30 min of aphidicolin (APH) treatment is comparable between wild-type and 
Rif1-null cells. (D) Time course monitoring the variation of -H2AX signal intensity after release from aphidicolin-induced S-phase arrest. Data were plotted 
as fold induction over time 0 mean value for each clone. Each time point represents the mean value of two independent Rif1
F/F + Cre clones and three wild 
type (Rif1 WT, Rif WT + Cre, and Rif1
F/F). The breaks in the lines indicate that the “no APH” is not a time point in a time course but the basal signal level. 
(E) Rif1
GT/GT pMEF and wild-type littermate controls were synchronized in G0 and released in BrdU to monitor S-phase progression. At the indicated time 
point, cells were collected and analyzed for BrdU content by FACS. One representative experiment out of two is shown.JCB • VOLUME 187 • NUMBER 3 • 2009   390
long tract gene conversion (LTGC). It contains the two halves 
of the blasticidin resistance gene, such that I-SceI–stimulated 
LTGC leads to the reconstitution of the wild-type gene. To re-
duce Rif1 levels, we used two Rif1-specific siRNAs and an 
irrelevant siRNA to luciferase as a control (Fig. 4 A). Quan-
titative immunoblots indicated that the siRNAs reduced Rif1 
levels by 30–60% compared with the level in the luciferase 
siRNA control cells (Fig. 4 A). Despite the modest knockdown 
of Rif1, we detected a significant effect on the efficiency of 
HDR. Cells transfected with siRNA #6 showed a threefold de-
crease in HDR, whereas siRNA #4 had a lesser effect (Fig. 4 B). 
As it has been shown for two other genes involved in HDR, 
BRCA1 and -2, depletion of Rif1 leads to a reduced S phase 
(Fig. S3 A; Patel et al., 1998; Kumaraswamy and Shiekhattar, 
2007). Diminished Rif1 levels also affected the efficiency of 
LTGC to an extent proportional to the magnitude of the knock-
down achieved by the different siRNAs.
Rif1 localizes at sites of replication 
fork stalling, mostly at pericentromeric 
heterochromatin
Given the possibility of a role for Rif1 at stalled replication forks, 
we examined the distribution of Rif1 during an unperturbed cell 
cycle. Cells were briefly labeled with BrdU such that sites of 
DNA replication could be detected with anti-BrdU antibodies 
under denaturing conditions. This technique allows the identifi-
cation of cells in different stages of S phase (Fig. 5; Nakamura 
et al., 1986; Dimitrova and Berezney, 2002). Immunofluores-
cence (IF) for Rif1 showed a punctuate nuclear staining pattern 
in late G1 with more prominent signals at the pericentromeric 
heterochromatin. In early and mid S phase, Rif1 progressively 
concentrated at pericentromeric heterochromatin. The Rif1 sig-
nal never overlapped with BrdU or proliferating cell nuclear   
antigen (unpublished data) except when pericentromeric hetero-
chromatin started to be replicated in mid S phase. At that 
stage, some BrdU foci colocalized with Rif1, again mostly at 
pericentromeric heterochromatin. In mid–late and late S phase, 
Rif1 appeared to have left the chromatin, showing a diffuse nu-
clear staining pattern. These data raised the possibility that Rif1 
has a specific function in the replication of certain regions of the 
genome, including the pericentromeric heterochromatin.
To determine whether the sites of BrdU–Rif1 colocaliza-
tion represent sites of fork stalling, we visualized stalled repli-
cation forks in aphidicolin-treated cells based on the presence 
of ssDNA using BrdU staining without denaturation (Fig. 6, A 
and B). Rif1 colocalized with ssDNA in only 12% of the un-
treated and 27% of the aphidicolin-treated BrdU-positive cells 
(Fig. 6 A and Fig. S5 B). In these cells, only a subset of the 
stalled forks showed the presence of Rif1 (Fig. 6 A), mostly, but 
not exclusively, at or near the pericentromeric heterochromatin 
(Fig. 6 A, bottom). Control experiments with Rif1
/ cells did 
not show foci of Rif1 coinciding with BrdU, establishing the 
specificity of the antibody (Fig. S3 B). To further verify the lo-
calization pattern of Rif1, we executed dual IF for the ssDNA-
binding protein RPA34 and Rif1 (Fig. S3 C). Consistent with 
the BrdU data, there was significant colocalization of Rif1 with 
a subset of the RPA34 foci. These data support the idea that the 
defect in their initial response to replication stress, as measured 
based on the level of -H2AX in cells treated with aphidicolin 
(Fig. 3 C). However, the aphidicolin-induced -H2AX response 
persisted in Rif1-null cells, which is consistent with a defect 
in the repair of aphidicolin-induced DNA damage (Fig. 3 D). 
To test more directly the requirements for Rif1 during normal 
S-phase progression, we synchronized in G0 Rif1
GT/GT pMEFs 
and analyzed their progression through one cell cycle. Rif1-null 
cells appeared to transit through S phase reproducibly slower 
than wild-type controls (Fig. 3 E and Fig. S2 E), which is con-
sistent with the presence of replication-induced DNA damage.
Rif1 stimulates homology-directed  
repair (HDR)
To further explore the role of Rif1 in the repair of S-phase dam-
age, we used a previously established assay for HDR, the main 
pathway for the repair of replication-associated DNA damage 
(Johnson and Jasin, 2000; Puget et al., 2005; for reviews see 
Cromie et al., 2001; Helleday, 2003). The HDR assay is based 
on a human U2OS cell line containing two tandem mutant   
copies of the gene encoding GFP. The first copy is promoterless 
and contains a small deletion in the 5 end; the second has a 
promoter but has an I-SceI site interrupting the GFP ORF. Upon 
introduction of I-SceI, an intact GFP gene can be generated 
through DSB repair by unequal sister or intrachromatid recom-
bination. The same reporter allows for assaying the efficiency of 
Figure 4.  Rif1 promotes HDR. (A and B) Knockdown of Rif1 decreases 
HDR efficiency. (A) Rif1 levels were reduced by two specific siRNAs, #4 
and #6, in U2OS#18. siRNA against luciferase (Luc si) was used as a 
control. Western blot showing a titration to validate the reduction of Rif1 
levels upon treatment with specific siRNAs. mTOR was used as a loading 
control. (B) Upon DSB induction by I-SceI transfection, HDR was evaluated 
by quantifying the amount of GFP-positive cells by FACS. The effect on HDR 
is expressed as the percentage of the luciferase siRNA. P-values are <0.05 
for both siRNAs. (C) LTGC efficiency was calculated by counting the num-
ber of colonies growing in the presence of blasticidin and normalized for 
plating efficiency. The effect of LTGC is expressed relative to the luciferase 
siRNA control. (B and C) Error bars represent SD.391 Rif1 modulates HDR at stalled forks • Buonomo et al.
centromeric heterochromatin. On the contrary, Rif1 is not re-
quired for 53BP1 or BLM localization at stalled replication 
forks (Fig. S5 D). This finding is in agreement with the fact that 
Rif1-deficient cells do not show an increase in sister chromatid 
exchanges (unpublished data).
Aberrant Rad51 aggregates in  
Rif1-deficient cells
Because we found that Rif1 contributes to the efficiency of HDR, 
we examined the behavior of one of the main effectors of homolo-
gous recombination, the protein Rad51, in Rif1-deficient MEFs. 
Co-IF for endogenous Rad51 and 53BP1 revealed that 15% of the 
Rad51-positive cells accumulated large aberrant Rad51 aggregates 
during S phase in the absence of Rif1 (Fig. 7 A). These types of 
structures were present exclusively in cells that were in S phase   
(Fig. 7 B; Starborg et al., 1996) and were virtually absent from wild-
type cells (Fig. 7, A and D). In contrast, the overall percentage of 
Rad51-positive cells was not significantly different between wild-
type and Rif1-null cells (Fig. 7 C). The presence of these aggregates 
could be explained if Rif1 had a direct or indirect role in promoting 
late steps of Rad51 turnover at the sites of recombination. Alterna-
tively, their presence could be an indirect consequence of the accu-
mulation of damage during the replication of specific regions of the 
genome that cannot be repaired in the absence of Rif1.
Rif1–BrdU colocalization at pericentromeric heterochromatin 
of unperturbed cells reflects sites of fork stalling.
Rif1 localization at stalled replication forks 
requires ATR and 53BP1
To further characterize Rif1 foci, we analyzed the presence of 
other fork-stalling response factors. The Rif1 foci at ssDNA   
always contained 53BP1 (Fig. S4 A), although there were ssDNA 
sites containing 53BP1 but no Rif1. Similarly, Rif1 foci at 
stalled forks colocalized with the BLM RecQ helicase, but not 
all BLM foci coincided with Rif1 signals (Fig. S4 B).
The localization of Rif1 at IR-induced DSBs is depen-
dent on ATM and 53BP1 (Silverman et al., 2004). In contrast, 
ATM
/  MEFs  retained  the  ability  to  accumulate  Rif1  at   
aphidicolin-induced ssDNA, whereas the absence of 53BP1 
abrogated this response (Fig. 6 B). This suggested that the ATR 
kinase might be involved in providing the signal responsible 
for the localization of 53BP1 and Rif1 at the stalled forks. Con-
sistent with this, the Rif1 pattern was significantly altered by 
treating the cells with the PI3-like kinase inhibitor caffeine 
(Fig. 6 B) or by inhibiting ATR with a specific short hairpin 
RNA (shRNA; Fig. S5, A–C). Together, the data suggest that 
Rif1 requires ATR and 53BP1 to localize to a subset of stalled 
replication forks, very often located in the proximity of peri-
Figure 5.  Rif1 binds chromatin before and during DNA replication but only seldom colocalizes with the replication fork in mid–late S phase and around 
pericentromeric heterochromatin. IF on wild-type MEFs for Rif1 (red) and BrdU visualized by denaturing BrdU staining (green). Late G1, early, mid, 
mid–late, and late S were identified by the BrdU staining pattern. Insets contain enlarged details of the indicated areas.JCB • VOLUME 187 • NUMBER 3 • 2009   392
for Rif1 for cellular and embryonic survival can be explained 
from the S-phase function of Rif1 documented in this study. 
We show that upon ATR activation and 53BP1 recruitment, 
Rif1 localizes at a subset of stalled replication forks, where it 
could be important to regulate HDR during replication. In-
deed, Rif1 deletion induces accumulation of chromatid-type 
genome instability and, as a consequence, renders cells hyper-
sensitive to aphidicolin and HU. We have also shown that Rif1 
Discussion
Our results identify Rif1 as a novel component of the DNA 
replication checkpoint, essential for embryonic development 
and normal DNA replication. We had previously shown that 
Rif1 was contributing to the inhibition of DNA replication in 
response to ATM activation by DSBs (Silverman et al., 2004). 
However, Rif1 is essential, whereas ATM is not. The requirement 
Figure 6.  Rif1 localizes to sites of replication stress. (A) IF on wild-type MEFs for Rif1 (red) and ssDNA visualized by nondenaturing BrdU staining (green). 
The bottom row shows an example of Rif1 localized at stalled replication forks near heterochromatin. (B) Rif1 localization at aphidicolin-induced sites of 
ssDNA is abolished in 53BP1-null cells and upon caffeine treatment. IF for Rif1 (red) and ssDNA (green) on ATM
/, 53BP1
/, and caffeine-treated wild-
type MEFs. All cells were treated with aphidicolin. (A and B) Insets contain enlarged details of the indicated areas.393 Rif1 modulates HDR at stalled forks • Buonomo et al.
(Nakamura et al., 2008). Therefore, we hypothesize that Rif1 
regulates  Rad51-dependent  homologous  recombination  at 
replication forks stalled in regions of the genome that are dif-
ficult to replicate like repetitive sequences or tight protein–
DNA complexes.
These findings can be reconciled with observations in   
yeast, in which Rif1 has a telomere-specific function. Budding 
localizes  at  stalled  replication  forks  preferentially  during 
mid–late S phase, often at/around replicating pericentromeric 
heterochromatin.  Centromeres,  like  telomeres,  are  highly   
repetitive  sequences  and  are  highly  recombinogenic  (Jaco   
et al., 2008; Nakamura et al., 2008). In particular, it was re-
cently shown that Rad51 function is essential to suppress gross   
chromosomal rearrangement at centromeres in fission yeast 
Figure 7.  Aberrant Rad51 aggregates in Rif1-deficient cells. (A) IF for Rad51 (green) and 53BP1 (red) in Rif1
F/F (left) and wild-type (right) MEFs treated 
with Cre and aphidicolin. Arrowheads point to aberrant Rad51 aggregates. Insets contain enlarged details of the indicated areas. (B) IF for Rad51 (green), 
Ki67 (red), and DAPI staining (blue) on Rif1
F/F MEFs treated with Cre and aphidicolin (aph). (C and D) Quantification of the percentage of Rad51-positive 
cells (C) and of the percentage of Rad51-positive (pos) cells containing Rad51 large aggregates (D). One representative experiment out of two is shown. 
wt, wild type.JCB • VOLUME 187 • NUMBER 3 • 2009   394
Materials and methods
Gene targeting
The mouse Rif1 locus contains 36 exons, with the second exon containing 
the ATG for the 2,426–amino acid ORF. The targeting strategy allows 
Cre-mediated deletion of exons 5, 6, and 7; the splicing of exon 4 to 
exon 8 generates a frame shift. The targeting vector was generated by 
recombineering (Lee et al., 2001) using bacterial artificial chromosome 
RCPI-23 395O2 (American Type Culture Collection) in Escherichia coli 
strain EL350. The first LoxP site was introduced in the unique EcoRV site 
upstream of exon 4 by inserting an oligonucleotide that also introduced 
SacI and BamHI restriction sites used for the analysis of targeting in ES 
cells. The unique EcoRI site 3 of exon 7 was used to insert a LoxP-FRT-
Neomycin
R(NeoR)-FRT cassette (gift from D. O’Carroll, European Molecu-
lar Biology Laboratory Monterotondo, Monterotondo, Italy). The construct 
was subcloned into the pDTA-TKIII vector, which allows double negative 
selection (DTA and TK genes), linearized with NotI, and electroporated 
into  Bruce4  C57BL/6  ES  cells.  Four  independent  ES  cell  clones  were 
injected by standard techniques into albino C57BL/6J blastocysts, and 
chimeras were evaluated based on coat color. Chimeric founders were 
crossed to C57BL/6J females, and the mice were kept in a pure C57BL/6J 
background. The NeoR cassette was removed by crossing the F1 mice 
with an FLPe deleter mouse strain (Jackson ImmunoResearch Laboratories, 
Inc.). Genotyping of mice and derived cells was performed by PCR with 
the  following  primers:  f1,  5-TTAGAGGAACTGAGGGGTAGGTAG-3;   
r1, 5-AACTGCAACTCTACTGAGGGAAG-3; and r2, 5-TGAAACCG-
TAGCCAGAAACTG-3. PCR generated a 78-bp product for the wild-type 
allele, a 138-bp product for the LoxP-modified (FLOX) allele, and a 246-bp 
product for the deleted (DEL) allele. The southern probes p1 and p2 were 
generated by PCR from genomic DNA with the following primers: p1 E3s, 
5-GAATTGTAGTTAATGATGGGCC-3; and E3a 5-TCTATGGATGTAGCT-
TAGTGGTACA-3; and p2 E8a, 5-TGGTTCACATCTACGATCCCA-3; and 
E8s 5-GAATTGTAGTTAATGATGGGCC-3.
Rif1
GT  mice  were  generated  from  an  ES  cell  clone  carrying  a 
trapped Rif1 allele (A045A01) available from the German Gene Trap 
Consortium (http://genetrap.gsf.de/). Chimeric founders were crossed to 
C57BL/6J females, and the mice were kept in a mixed 129/C57BL/6J 
background. Genotyping of mice and derived cells was performed by PCR 
with the following primers: f2, 5-GCTAGTCTAGGCACCAGGAACC-3; 
f3,  5-AGGAGAAAATACCGCATCAGG-3;  and  r3,  5-TCCTCAGCAT-
CAACCAAAGAG-3. The PCR products were 135 bp and 190 bp for 
the  wild-type  and  GT  allele,  respectively.  The  southern  probe  p3  was 
generated by PCR from genomic DNA with the following primers: E22s, 
5-TCAGATTGGTCCAGAAAGAA-3;  and  E24a,  5-CATTCCACAA-
CAGAGCACTCT-3. The Neo probe was obtained by digesting the plas-
mid pZero2-LoxP-Neo-LoxP with PstI and NcoI and isolating the fragment 
corresponding to part of the NeoR ORF.
Generation of MEFs, conditional deletion of Rif1, and cell manipulation
MEFs were generated from E12.5 embryos according to standard pro-
tocols and propagated in DME high glucose, 15% heat-inactivated FBS 
(Invitrogen), 100 U/ml penicillin, 0.1 mg/ml streptomycin, 0.2 mM l-Gln, 
0.1  mM  nonessential  amino  acids,  and  50  µM  -mercaptoethanol.  To 
immortalize primary MEFs, early passage (P2) cells were infected with   
pBabeSV40LT (gift from G. Hannon, Cold Spring Harbor Laboratory, Cold 
Spring Harbor, NY).
ATM
/  MEFs  were  prepared  from  heterozygous  intercrosses  of 
ATM
+/  mice  (129S6/SvEvTac-Atmtm1Awb/J;  Jackson  ImmunoResearch 
Laboratories,  Inc.).  53BP1
/  MEFs  were  prepared  from  heterozygous 
intercrosses of mice provided by J. Chen (Yale University School of Medi-
cine, New Haven, CT). MEFs were immortalized with SV40LT as described 
in the previous paragraph.
For Cre-mediated deletion of the Rif1 gene, cells were infected six 
times at 6–8-h intervals with the supernatant from Phoenix packaging cells 
(American Type Culture Collection) transfected by standard calcium phos-
phate protocol with either empty pWZL-hygro (gift from S. Lowe, Cold 
Spring Harbor Laboratory, Cold Spring Harbor, NY) or pWZL-hygro-CRE. 
Cells were split into medium containing hygromycin B (Sigma-Aldrich) at 
90 µg/ml and grown for 3 d.
Growth curves were determined by plating 34,000 or 68,000 cells 
per well of a 6-well plate in triplicate for each day of the experiment, for 
immortalized and primary cells, respectively. Cells were trypsinized and 
counted with a Z2 counter (Beckman Coulter).
Aphidicolin sensitivity was measured by plating 1,400 and 1,000 
cells per well of a 6-well plate for Rif1
F/F and wild-type immortalized MEFs, 
yeast strains that survive without telomerase maintain their 
telomeres  either  through  Rad51-dependent  HDR  (type  I 
survivors)  or  through  a  less  understood  Rad50-dependent 
pathway (type II survivors; Lundblad and Blackburn, 1993; 
Lendvay et al., 1996; Le et al., 1999; Teng and Zakian, 1999). 
In the absence of Rif1, the frequency of type I survivors is 
diminished (Teng et al., 2000), which is consistent with a 
role for Rif1 in the Rad51 pathway. Data from fission yeast 
Rif1 can also be explained from an HDR perspective. When 
the telomeric protein Taz1 is absent, fission yeast telomeres 
can become entangled, presumably reflecting a pathological 
product of an HDR event taking place after replication fork 
arrest (Miller and Cooper, 2003; Miller et al., 2006). Rif1 de-
ficiency suppresses the lethality associated with this process, 
which is consistent with a role in HDR (Miller et al., 2005). 
Therefore, modulation of Rad51-dependent HDR could be 
Rif1’s function conserved during evolution. The finding that 
Rif1 depends on 53BP1 and positively contributes to HDR 
execution is in apparent conflict with observations on 53BP1-
null  MEFs.  Deletion  of  53BP1  does  not  sensitize  cells  to 
aphidicolin (unpublished data) and promotes HDR (Adams 
et al., 2005; Xie et al., 2007). This discrepancy could be ex-
plained if Rif1 is one of several factors that act downstream 
of 53BP1 to navigate replication problems such that its dele-
tion creates an imbalance in HDR that leads to pathologi-
cal products. One interesting possibility is that Rif1 inhibits 
(directly or not) BLM, which has been proposed to have a 
53BP1-regulated role at stalled forks (Sengupta et al., 2004; 
Bugreev, 2007; Tripathi et al., 2007, 2008). Inhibition of BLM 
by Rif1 would be consistent with genetic data on the survi-
vor pathway in yeast, which allows budding yeast to prolifer-
ate without telomerase (McEachern and Haber, 2006). The 
yeast orthologue of BLM, Sgs1, is required for the type II 
(Rad50 dependent) survivor pathway (Johnson et al., 2001),   
but this requirement is alleviated by the deletion of Rif1 
(Tsai et al., 2006). Because Rif1 localizes only to a subset 
of the stalled replication forks, the interplay between BLM 
and Rif1 could direct the choice between different types of 
HDR at single forks, depending on the DNA sequence and 
chromatin context.
Finally, the finding that Rif1 plays a role in HDR is rele-
vant to the recent identification of Rif1 mutations in human 
breast cancer. One breast cancer cell line (HCC2218) was found 
to have two mutations in Rif1 (E1784K and D1955H; Sjöblom 
et al., 2006), and a second breast cancer cell line (HCC1806) 
carries  a  translocation  that  truncates  Rif1  after  exon  21 
(Howarth et al., 2008). According to our data on Rif1/-GEO, 
this truncation is expected to be nonfunctional. The possible in-
activation of Rif1 in sporadic cases of breast cancer is of interest 
with regard to the BRCA2 gene, whose inactivation predisposes 
to breast and ovarian cancer. Like Rif1, BRCA2 is implicated in 
the Rad51 pathway (for review see Thorslund and West, 2007). 
Given the current interest in treating BRCA2-deficient breast 
cancer with therapies based on their inability to execute HDR 
efficiently (Bryant et al., 2005; Farmer et al., 2005), it may be 
useful to consider sporadic tumors with Rif1 mutations for this 
treatment approach.395 Rif1 modulates HDR at stalled forks • Buonomo et al.
Analytical Technologies). After application of the threshold in channel 1 
(DAPI), objects were identified and masked. The images and masks were 
visually inspected for accuracy. Then, the percentage of cells with a mean 
intensity signal of channel 2 >50 was calculated (n > 100) for each condi-
tion and normalized to the percentage of the same cell line at time 0.
Western blotting
To monitor Chk1 Ser345 phosphorylation in response to aphidicolin, cells 
were treated for 3 h and 30 min with 5 µM aphidicolin and collected. 
Control irradiated NIH3T3 were treated with 5 Gy and allowed to recover 
for 30 min before preparing protein extracts. Cells were collected by tryp-
sinization, rinsed in PBS, directly lysed in 2× Laemmli buffer, and passed 
through  a  29-gauge  insulin  syringe.  Alternatively,  cells  were  lysed  in   
50 mM Tris-HCl, pH 7.4, 1% Triton X-100, 0.1% SDS, 150 mM NaCl,   
1 mM EDTA, phosphatase, and protease inhibitors. Chromatin-bound pro-
teins were extracted by increasing the NaCl concentration to 500 mM. The 
extract was centrifuged for 10 min at 13,200 rpm at 4°C, and the super-
natant was recovered. Proteins were separated by gel electrophoresis and 
blotted according to standard protocols. All of the Western blots, with the 
exception of phospho–Ser345 Chk1, were blocked in 5% milk/PBS/0.1% 
Tween, and the primary antibody was incubated in 1% milk/PBS/0.1% 
Tween. For the anti-phospho–Ser345 Chk1 antibody (Cell Signaling Tech-
nology), the manufacturer’s instructions were followed.
shRNA, siRNA, and sister chromatid recombination assay
Knockdown of ATR in wild-type or ATM
/ MEFs was performed as de-
scribed previously (Denchi and de Lange, 2007). In brief, cells plated on 
coverslips were infected four times in 24 h with retroviruses carrying   
either the ATR or the control luciferase shRNA. After 24 h in 2 µg/ml puro-
mycin and 3 µM BrdU, cells were incubated for 3 h in 5 µM aphidicolin 
and processed for IF as described in the IF section. Sister chromatid re-
combination assay was performed using U2OS#18 (gift from R. Scully, 
Harvard University, Cambridge, MA) as described previously, with minor 
modifications (Puget et al., 2005). In brief, 50,000 cells were plated per 
well of a 12-well plate in triplicate for each siRNA. siRNA transfections 
were performed as described previously (Silverman et al., 2004), except 
for  the  use  of  DharmaFECT  Duo  (Thermo  Fisher  Scientific)  instead  of   
Oligofectamine (Invitrogen). The sequences of siRNA #4 and #6 and   
luciferase were published previously (Silverman et al., 2004). The siRNAs 
were synthesized either by Thermo Fisher Scientific or Mycrosynth. 1 d after 
the second transfection, the medium was changed, and cells were col-
lected for Western blot analysis and for blasticidin selection. 250,000 
cells were plated in duplicate in a 10-cm dish and, after 24 h, were 
switched to full medium containing 5 µg/ml blasticidin. 200 cells were 
also plated in a 6-cm dish in triplicate to calculate plating efficiency. Cells 
were collected for GFP FACS at 48 h after the second transfection. During 
the FACS analysis, at least 30,000 events per sample were acquired. 
Statistical analysis was performed using a standard t test with a two-
tailed distribution and equal variance.
Antibodies
Rabbit anti–mouse Rif1 serum 1240 was raised against a keyhole limpet 
hemocyanin–conjugated peptide spanning amino acids 401–424 of the 
mouse Rif1 sequence. The antibody was affinity purified and used at a 
1:10,000 dilution for IF and Western blotting. Other antibodies used in 
this study were anti-53BP1 (1:1,000; Novus Biologicals), a mouse anti-
53BP1 serum generated against the C-terminal 312 amino acids of human 
53BP1 and fused to GST (1:2,000), anti-BLM (1:200; Abcam), anti-RPA 
(1:500; GeneTex, Inc.), anti-Ki67 (1:1,000; BD), anti–-H2AX (1:1,000; 
Bethyl  Laboratories,  Inc.),  and  anti-Rad51  (1:2,500  for  IF;  gift  from   
R. Kanaar, Erasmus Medical Center, Rotterdam, Netherlands; van Veelen 
et al., 2005). For Western blotting, anti-Chk2 (BD) was used at 1:1,000, 
anti-Chk1 (Santa Cruz Biotechnology, Inc.) was used at 1:200; anti- 
phospho–Ser345 Chk1 (Cell Signaling Technology) was used at 1:1,000, anti-
ATR (Santa Cruz Biotechnology, Inc.) was used at 1:500, anti–mammalian 
target  of  rapamycin  (mTOR;  Cell  Signaling  Technology)  was  used  at 
1:1,000, and anti–cyclin A (Cell Sciences) was used at 1:1,000.
Online supplemental material
Fig.  S1  shows  that  insertional  inactivation  of  Rif1  leads  to  embryonic   
lethality and reduced proliferation of MEFs. Fig. S2 exemplifies that Rif1-
null cells exhibit a reduced S-phase index and are hypersensitive to HU, 
as sensitive as wild-type cells to ICRF-193, and only mildly sensitive to   
-irradiation. Fig. S3 shows a decreased S-phase index in cells treated with 
Rif1-specific siRNAs and demonstrates the specificity of IF with anti–mouse Rif1   
antibody 1240 and Rif1–RPA34 colocalization. Fig. S4 illustrates that Rif1 
respectively, in triplicate. After 24 h, cells were either left untreated or 
treated for 24 h with the different doses of aphidicolin, washed three times 
with PBS, and incubated in growth media for about 1 wk. After rinsing with 
PBS, cells were fixed for 10 min in a solution containing 50% methanol, 
7% glacial acetic acid, and 0.1% Coomassie brillant blue. The number of 
colonies with >20 cells was counted. MMC sensitivity was tested in the 
same conditions, except that the drug treatment was performed only for   
2 h and 30 min.
G0 synchronization of pMEFs was obtained by 5 d of contact inhibi-
tion and 48 h of serum starvation (0.1% FBS). Cells were pulsed with   
10 µM BrdU for 1 h and subsequently released in 15% FBS medium con-
taining 10 µM BrdU by plating 1.5 × 10
6 cells per 10 cm.
BrdU staining for FACS analysis
Asynchronous cell populations were pulsed for 30 min with 10 µM BrdU. 
After fixation in 70% ethanol at 20°C, 3 × 10
5 cells were stained accord-
ing to the BD protocol, with 10–15 µl per sample of anti-BrdU FITC conju-
gated (BD). The samples were analyzed by FACS on a FACSCalibur System 
One laser (488 nm; BD), and the data were analyzed with FlowJo software 
(Tree Star, Inc.).
Aphidicolin treatment, metaphase spreads, and spectral karyotyping 
analysis (SKY)
Cells were treated for 24 h with or without 0.3 µM aphidicolin, followed 
by 4 h with 0.2 µg/ml colcemid, and then collected by trypsinization and 
treated according to standard protocols to prepare metaphase chromo-
somes. Metaphase spreads were analyzed either by DAPI staining or by 
SKY (Liyanage et al., 1996) using paint mixtures from Applied Spectral 
Imaging  according  to  the  manufacturer’s  protocol.  Imaging  was  per-
formed on a microscope (BX-61; Olympus) equipped with an interferome-
ter driven by a desktop computer and SpectraView software (Applied 
Spectral Imaging).
IF
Cells grown on coverslips were rinsed with PBS and extracted for 10 min 
at 4°C in Triton buffer (0.5% Triton X-100, 20 mM Hepes, pH 7.9, 50 mM 
NaCl, 3 mM MgCl2, and 300 mM sucrose), fixed for 10 min in 3% para-
formaldehyde/2%  sucrose  at  room  temperature,  and  permeabilized 
again for 10 min at 4°C in Triton buffer. IF was performed as described 
previously (Zhu et al., 2000), with minor modifications. In brief, cells were 
blocked in PBG buffer (0.2% cold fish gelatin [Sigma-Aldrich] and 0.5% 
BSA) for 30 min at room temperature. The primary antibodies were di-
luted in PBG and incubated for 1 h at room temperature. The fluorescent-
conjugated secondary antibodies were also diluted in PBG and incubated 
for 45 min.
Nondenaturing BrdU IF was performed according to Raderschall 
et al. (1999). In brief, cells were labeled with 3 µM BrdU for 25 h. After 
harvesting, IF was performed as described (Raderschall et al., 1999),   
using the BD anti-BrdU antibody at 1:1,000. An appropriate secondary 
fluorescent-conjugated anti–mouse antibody was used to detect the BrdU.
Denaturing BrdU IF was performed by pulsing cells for 30 min with 
10 µM BrdU. Cells were pre-extracted and fixed as described in the previ-
ous paragraph. 100 U/ml DNaseI and 3 mM MgCl2 were added to the 
primary antibody mix to denature the DNA.
For the triple staining, either one or both primary rabbit antibodies 
were directly conjugated to the fluorophore using the Zenon kit (Invitrogen) 
according to the manufacturer’s instructions. Anti-BrdU antibody was de-
tected using a Cy5-conjugated anti–mouse secondary antibody (Millipore). 
To  assay  the  effect  of  PI3-like  kinase’s  inhibition  on  Rif1  localization  at 
stalled replication forks, wild-type MEFs were incubated for 3 h with 10 mM   
caffeine before aphidicolin treatment. Caffeine was maintained during 
the aphidicolin treatment. Slides were mounted in embedding medium   
(1 mg/ml p-phenylene diamine [Sigma-Aldrich] in 1× PBS and 90% glyc-
erol). Images were acquired with a microscope (Axioplan 2 [Carl Zeiss, 
Inc.], DM6000 [Leica], or confocal TCS SP5 [Leica]) with a 63× 1.4 NA oil 
objective. The camera used was either a C4742-95 (Hamamatsu Photonics) 
or a DFC340FX (Leica). The acquisition software used was either Open-
Lab (PerkinElmer) or LAS AF (Leica). Contrast adjustment and cropping was 
performed in Photoshop (Adobe), and figures were composed in Illustrator 
(Adobe). For the confocal images (Fig. 7), maximum projection is shown.
In the case of the quantification of the -H2AX signal over the time 
course (Fig. 3, C and D), cells from two Rif1
F/F + Cre and three wild type 
were imaged using a wide-field DM6000 microscope with a 63× objective 
(30 fields from each time point). Two channels were imaged: channel 1 to 
find the nuclei (DAPI) and channel 2 to image the -H2AX signal. The mean 
intensity of channel 2 was quantified by using MetaMorph software (MDS JCB • VOLUME 187 • NUMBER 3 • 2009   396
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